The rebrand, says the company, is an effort to “clearly indicate its specialization as a manufacturer of gummy vitamin, mineral and supplement products.”
Island Abbey Foods has rebranded to Island Abbey Nutritionals (Prince Edward Island, Canada), according to a press release from the company. An established manufacturer of gummies and honey lozenges, the company has brought new manufacturing capabilities online such as increased capacity, new technology, including a heavy suspension skid that allows for market-leading loads of active ingredients within a gummy, and increased capacity of its honey gummies. The rebrand, says the company, is an effort to “clearly indicate its specialization as a manufacturer of gummy vitamin, mineral and supplement products.”
“This is an exciting time for Island Abbey Nutritionals. Our change of name cements our strategic focus on the health supplements industry and ushers in a new era of gummy manufacturing for the company,” said CEO Dean Williams, in a press release. “We have invested considerably in order to increase our production capabilities and to broaden the opportunity for brands to benefit from our new capabilities. Our new gummy line has a heavy suspension skid that enables us to manufacture great tasting gummies containing higher volumes of active ingredients that are traditionally difficult to manufacture in gummy form, e.g., calcium and magnesium gummies.”
Island Abbey Nutritionals explains that the company’s new manufacturing capabilities were made possible by the installation of top-of-the-line gummy production equipment commissioned from Tanis. “Island Abbey Nutritionals has recently installed an outstanding confectionery production line in their new facility. We have found their team extremely professional, knowledgeable, and collaborative to work with,” said Victor Tanis, the company’s spokesperson, in a press release. “This has been a project undertaken over several years, so we had the additional strains that the COVID-19 pandemic contributed to the project, but the team at Island Abbey Nutritionals has been proactive and positive throughout and we are very pleased to see the line up and running so well.”
As a major employer on Prince Edward Island (PEI), the company also works closely with PEI BioAlliance, a private sector-led not-for-profit organization dedicated to building the bioscience industry on Prince Edward Island. “Island Abbey Nutritionals is a great success story of the growing bioscience sector in PEI,” said Roy Francis, CEO of PEI BioAlliance. “They have expanded their markets to dozens of international countries and are continually innovating new products, and we look forward to working together and supporting them as a key organization in our PEI bioscience cluster.”
Looking ahead, Island Abbey Nutritionals’ CEO announced that the company was working on new ingredients and “benefit-driven gummies” for its clients, “From adaptogens to botanicals, energy to sleep, workout prep to immunity boosts.”
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.